Results

Total Results: 1,726 records

Showing results for "tables".

1. Data-Points-7-Tables (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/data-points-7-tables.pdf
   May 29, 2025 - 1 Table 1. … Digestive and Urinary Neoplasms 13 Other Neoplasms 14 Benign Neoplasms of Skin, Breast, Eye 7 Table … Monoclonal antibodies Trastuzumab 12 months 88.4 9.0 2.0 2.2 10.9 0.5 1.4 4.5 5.5 11 Table … Kinase inhibitors Trastuzumab American Indian/Alaska Native 0.3 * * * 0.0 * * * * 28 Table

2. Data-Points-7-Tables (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/data-points-7-tables.xls
   May 29, 2025 - OT.1 Table 1. … Digestive and Urinary Neoplasms 13 Other Neoplasms 14 Benign Neoplasms of Skin, Breast, Eye OT.3 Table … Antibodies TRASTUZUMAB 12 months 88.44% 8.99% 2.03% 2.23% 10.95% 0.46% 1.44% 4.45% 5.49% OT.4 Table … 0.1% Kinase Inhibitors TRASTUZUMAB American Indian/Alaska Native 0.3% - - - 0.0% - - - - OT.5 Table

3. Data-Points-9 Tables (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/data-points-9_tables.xlsx
   January 01, 2009 - 1. Antidiab Prevalence of Drugs by Antidiabetic Class, Among Medicare Parts A, B, and D FFS Population With Diabetes, by Age, Gender, and Race, 2006-2009 Age is calculated as of December 31 of the year. Note: A dash signifies small cell count (<11). Breakdown Category Year Alpha Glucosidase Inhibitors Amylin A…

4. Data-Points-6-Tables (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/data-points-6-tables.xls
   January 01, 2006 - 1 Number of Beneficiaries With at Least One Part A, B, or D Drug Claim for a Biologic of Interest (among continuously enrolled AB FFS population) by Class of Drug and Active Ingredient, 2006-2009 Note: A single period (.) signifies a small cell count (less than 11). Use filters to rank by beneficiary count. …

5. Appendix-E-Evidence-Tables-E1-E4 0 (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/Appendix-E-Evidence-Tables-E1-E4_0.xlsx
   May 29, 2025 - Study Characteristics Table E-1. … not reported; RCT = randomized controlled trial; THC = tetrahydrocannabinol; U.S. = United States Table … Primary Outcomes Table E-2. … Secondary Outcomes Table E-3. … Adverse Events Table E-4.

6. Cannabis-2022-Surv-Rep-3-Tables-F1-4 (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-tables-F1-4.xlsx
   January 01, 2022 - Study Characteristics Table F-1. … Table F-1. Cannabis RCTs study characteristics F-2. Can. Primary Outcomes Table F-2. … Secondary Outcomes Table F-3. … Table F-3. Cannabis RCTs secondary outcomes F-4. Can. Adverse Events Table F-4. … Table F-4. Cannabis RCTs adverse events

7. Cannabis-2022-Surv-Rep-4-Tables-G1-2 (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-G1-2.xlsx
   January 01, 2022 - Table G-1. ROB RCTs Table G-1. Risk of bias of cannabis RCTs Author, Year Randomization Adequate? … Yes Yes Yes Yes Yes Yes Yes No Moderate Zubcevic, 2022 Yes Yes Yes Yes Yes Unclear Yes Yes Yes Low Table … Risk of bias of cannabis RCTs Table G-2. ROB Cohort Studies Table G-2. … Yes No Yes Unclear Yes No No Yes High Ware, 2015 Unclear Unclear Unclear No Yes Yes/Yes No Yes High Table

8. Cannabis-2022-Surv-Rep-4-Tables-F1-4 (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-F1-4.xlsx
   January 01, 2022 - Study Characteristics Table F-1. … Table F-1. Cannabis RCTs study characteristics F-2. Can. Primary Outcomes Table F-2. … Secondary Outcomes Table F-3. … Table F-3. Cannabis RCTs secondary outcomes F-4. Can. Adverse Events Table F-4. … Table F-4. Cannabis RCTs adverse events

9. Cer-250-Cannabis-Tables-E1-E4-2022-Update 0 (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-tables-e1-e4-2022-update_0.xlsx
   January 01, 2022 - Study Characteristics Table E-1. … Table E-1. Cannabis RCTs study characteristics E-2. Can. Primary Outcomes Table E-2. … Secondary Outcomes Table E-3. … Table E-3. Cannabis RCTs secondary outcomes E-4. Can. Adverse Events Table E-4. … Table E-4. Cannabis RCTs adverse events

10. Cannabis-2023-Surv-Rep-4-Tables-F1-F-2 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-F1-F-2.xlsx
    January 01, 2023 - Table F-1. ROB RCTs Table F-1. Risk of bias of cannabis RCTs Author, Year Randomization Adequate? … Yes Yes Yes Yes Yes Yes Yes No Moderate Zubcevic, 2022 Yes Yes Yes Yes Yes Unclear Yes Yes Yes Low Table … Risk of bias of cannabis RCTs Table F-2. ROB Cohort Studies Table F-2. … Yes No Yes Unclear Yes No No Yes High Ware, 2015 Unclear Unclear Unclear No Yes Yes/Yes No Yes High Table

11. Cer-250-Cannabis-Tables-F1-F2-2022-Update 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-tables-f1-f2-2022-update_0.xlsx
    January 01, 2022 - Table F-1. ROB RCTs Table F-1. Risk of bias of cannabis RCTs Author, Year Randomization Adequate? … No Yes Yes Not Reported Yes Yes Yes High Zajicek, 2012 Yes Yes Yes Yes Yes Yes Yes Yes No Moderate Table … Risk of bias of cannabis RCTs Table F-2. ROB Cohort Studies Table F-2. … Yes No Yes Unclear Yes No No Yes High Ware, 2015 Unclear Unclear Unclear No Yes Yes/Yes No Yes High Table

12. Digestible Carbohydrate Intake and Maternal-Infant Outcomes: Appendix E Tables (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/carbohydrate-intake-appendix-e.xlsx
    July 15, 2025 - Digestible Carbohydrate Intake and Maternal-Infant Outcomes: Appendix E Tables E-1. … ROB RCT Table E-1. Risk of bias of RCTs Author, Year Is randomization adequate? … ROB Cohort Table E-2.

13. Cer-250-Cannabis-2025-Surv-Rep-Update-Tables-F1-2 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2025-surv-rep-update-tables-f1-2.xlsx
    January 01, 2025 - Table F-1. ROB RCTs Table F-1. Risk of bias of cannabis RCTs Author, Year Randomization Adequate? … Yes Yes Yes Yes Yes Yes Yes No Moderate Zubcevic, 2022 Yes Yes Yes Yes Yes Unclear Yes Yes Yes Low Table … Risk of bias of cannabis RCTs Table F-2. ROB Cohort Studies Table F-2. … Yes No Yes Unclear Yes No No Yes High Ware, 2015 Unclear Unclear Unclear No Yes Yes/Yes No Yes High Table

14. Cannabis-App-F1-F4-Tables-Surveillance-Report-2 0 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f1-f4-tables-surveillance-report-2_0_0.xlsx
    May 29, 2025 - Study Characteristics Table F-1. … not reported; RCT = randomized controlled trial; THC = tetrahydrocannabinol; U.S. = United States Table … Primary Outcomes Table F-2. … Secondary Outcomes Table F-3. … Adverse Events Table F-4.

15. Cer-250-Cannabis-2025-Surv-Rep-Update-Tables-E1-4 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2025-surv-rep-update-tables-e1-4.xlsx
    January 01, 2025 - Study Characteristics Table E-1. … THC/30 mg CBD per day) Placebo Median 10 capsules (range 3–10 capsules) 8 Short Government Low Table … Primary Outcomes Table E-2. … Secondary Outcomes Table E-3. … Adverse Events Table E-4.

16. Cer-250-Cannabis-2024-Surv-Rep-Update-Tables-E1-4 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-tables-e1-4.xlsx
    January 01, 2024 - Study Characteristics Table E-1. … THC/30 mg CBD per day) Placebo Median 10 capsules (range 3–10 capsules) 8 Short Government Low Table … Primary Outcomes Table E-2. … Secondary Outcomes Table E-3. … Adverse Events Table E-4.

17. Cer-250-Cannabis-2024-Surv-Rep-Update-Tables-F1-2 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-tables-f1-2.xlsx
    January 01, 2024 - Table F-1. ROB RCTs Table F-1. Risk of bias of cannabis RCTs Author, Year Randomization Adequate? … Yes Yes Yes Yes Yes Yes Yes No Moderate Zubcevic, 2022 Yes Yes Yes Yes Yes Unclear Yes Yes Yes Low Table … Risk of bias of cannabis RCTs Table F-2. ROB Cohort Studies Table F-2. … Yes No Yes Unclear Yes No No Yes High Ware, 2015 Unclear Unclear Unclear No Yes Yes/Yes No Yes High Table

18. Cannabis-2023-Surv-Rep-4-Tables-E-1-E-4 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-E-1-E-4.xlsx
    January 01, 2023 - Study Characteristics Table E-1. … Table E-1. Cannabis RCTs study characteristics E-2. Can. Primary Outcomes Table E-2. … Secondary Outcomes Table E-3. … Table E-3. Cannabis RCTs secondary outcomes E-4. Can. Adverse Events Table E-4. … Table E-4. Cannabis RCTs adverse events

19. Table 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-end-of-life-indicators-symposium_research.pdf
    April 01, 2010 - Table 1 The DEcIDE (Developing Evidence to Inform Decisions about Effectiveness) network is part … .................................................................................................8 Table … the summaries of each domain’s priority issues and potential solutions, which are also summarized in Table … 4):289-292. 9 http://www.iom.edu/ Effective Health Care Research Report Number 20 Table

20. Digestible Carbohydrate Intake and Maternal-Infant Outcomes: Appendix D Tables (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/carbohydrate-intake-appendix-d.xlsx
    January 01, 2019 - Digestible Carbohydrate Intake and Maternal-Infant Outcomes: Appendix D Tables D-1. … Study Characteristics Table D-1. … KQ1_Outcomes Table D-2. … KQ2_Outcomes Table D-3. … KQ3_Outcomes Table D-4.